The Medicine Shoppe Recalls Bi-Est Progesterone Capsules Due to Processing Control
The Medicine Shoppe Pharmacy is recalling Bi-Est (8:2)/Progesterone capsules in Florida due to a lack of processing control.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity where the hazard is unlikely to cause serious adverse health consequences but may cause temporary or medically reversible harm.
Plain-English summary
The Medicine Shoppe Pharmacy in Port Charlotte, Florida, is recalling Bi-Est (8:2)/Progesterone 2/100 mg/mL capsules, 90-count bottles. The recall is limited to Lot 45239, which has a discard-by date of 9/16/2020. The product was distributed in Florida.
The recall was initiated due to a lack of processing control. This is a Class II recall, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers who have this product should stop using it and contact their healthcare provider or the pharmacy for instructions on how to return the product or obtain a replacement.
The recalled product
- Product
- Bi-Est (8:2)/Progesterone 2/100 mg/mL capsule 90 caps bottle, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL
- Manufacturer
- The Medicine Shoppe Pharmacy
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 45239 Discard by: 9/16/2020
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 54 recalled by The Medicine Shoppe Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 54 products in this recall →Related recalls
Same manufacturer · The Medicine Shoppe Pharmacy
See all →- SevereBi-Est Cream Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateDiethylstilbestrol Capsules Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateHydrocortisone Cream Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateTestosterone Gel Recalled by Florida Pharmacy for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateParegoric Alternate Elixir Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
Same hazard · processing control
See all →- ModerateErgotamine Tartrate and Caffeine Suppositories Recalled for Processing Control Issues
FDA (Drugs) · 2020-04-22
- ModerateEstradiol Vaginal Cream Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
Similar recalls
- ModerateProgesterone 100 mg SR Capsules Recalled for Lack of Processing Controls
FDA (Drugs) · 2019-02-06
- SevereMasterPharm Recalls Progesterone Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- SevereBi-Est 80:20 Progesterone Capsules Recalled for Penicillin Cross Contamination
FDA (Drugs) · 2015-09-09
- SevereProgesterone Injection Recalled Due to Sterility Concerns
FDA (Drugs) · 2013-07-10
- ModerateProgesterone Cream Recalled for Lack of Processing Controls
FDA (Drugs) · 2019-02-06
- ModerateMasterPharm Recalls Progesterone Tablets Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05